Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Dillard’s Introduces Shea Leigh Mills for Gianni Bini
-
Explosive Investigative Thriller Bribe, Inc. to Make U.S. Premiere Amid Global Reckoning Over Corruption
-
Schellman Now Authorized to Conduct Classified DoD Assessments; also Reauthorized as a CMMC 3PAO
-
SS Innovations Achieves Significant Milestones in 2024
-
Mindwell Solutions Group Holdings, A TransGlobal Assets Inc. (OTC: TMSH) Subsidiary, Announces Strategic Acquisition of Manifest Technologies Group Assets to Enhance AI-Powered Financial Solutions
-
Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
LB Pharmaceuticals Presents New Data from Phase 2 Clinical Trial of LB-102 at the 2025 Annual Congress of the Schizophrenia International Research Society
-
The Now Corporation (OTC: NWPN) and Green Rain Solar Inc. Partner with Chronical Electric to Bring High-Speed EV Charging and Battery Storage to Rochester, NY
-
Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
-
Artelo Biosciences to Present Novel Scientific Insights for ART26.12 at the 4th ACE Drug Discovery Summit on April 3, 2025
-
GCL and the Hainan Animation and Gaming Association Announce Strategic Partnership to Drive Regional Gaming Initiatives
-
Safety Shot Provides Business Update from CEO Jarrett Boon
-
Data Storage Corporation Reports 2024 Fiscal Year Financial Results and Provides Business Update
-
Investview, Inc. (“INVU”) Reports Full Year 2024 Financial Results, Operational Highlights and a Year-End Message from the CEO
-
Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
-
Giftify, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
-
Enovix Reports Progress on 2025 Smartphone Launch
-
authID Announces Pricing of Approximately $8,150,000 Million Registered Direct Offering
-
HomesToLife Ltd to Hold Conference Call April 11 at 8:30 a.m. ET to Discuss Financial Results for Fiscal Year Ended December 31, 2024
-
HeartCore Reports 2024 Financial Results
-
AMD Completes Acquisition of ZT Systems
-
Critical Metals Corp.’s Tanbreez Valued at $3 Billion With IRR of 180% and Significant Additional Upside Potential
-
Intelligent Bio Solutions Expands Middle East Market Reach with Arabic Integration in Drug Screening System
-
Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial
-
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
-
GEN Korean BBQ Opens First North Carolina Location in Cary
-
Total voting rights
-
Velcan Holdings: Share buyback program - weekly statement
-
Platform9 Releases Free Community Edition so All Virtualization Practitioners Can Experience the Easiest Private Cloud
-
Opus Genetics Announces Financial Results for Full Year 2024
-
Navigator Gas Announces Successful Completion of US$40 million Tap Issue of Existing 2024 Senior Unsecured Bonds in the Nordic Bond Market
-
Transactions in connection with share buy-back program
-
Justin Sun: Forbes Cover Marks New Beginning, Vows 40-Year Commitment to Crypto Industry
-
Costamare Inc. Announces Costamare Bulkers Holdings Limited Virtual Analyst And Investor Day April 9
-
Costamare Inc. Announces Costamare Bulkers Holdings Limited Virtual Analyst And Investor Day April 9
-
WANG AND LEE GROUP, INC. ANNOUNCES STRATEGIC INVESTMENT IN TROOPS, INC. TO DRIVE INNOVATION IN SMART BUILDING SOLUTIONS AND EXPAND ESG TOKEN REWARD ECOSYSTEM
-
Vishay Intertechnology Announces 2025 Annual Meeting of Stockholders
-
Greenheart Gold Announces Trading on the OTCQB Venture Market in the United States
-
Oncotelic Therapeutics Publishes New Research Demonstrating Positive Prognostic Impact of Methylated TGFB2 and MGMT in Adult Glioblastoma Patients, Introduces Interactive PDAOAI
-
CERo Therapeutics Holdings, Inc. Receives FDA Clearance of Second Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Lead Compound CER-1236 in Solid Tumors
-
Voltus Registers First Resource Under NYISO’s Distributed Energy Resource Participation Model
-
Xeriant Announces Successful Fire Test of NEXBOARD™
-
iRhythm Unveils New Real-World Data at ACC.25 Demonstrating the Benefits of Zio® Long-Term Continuous Monitoring for Arrhythmia Detection
-
NeOnc Technologies Holdings, Inc. Receives Rare Pediatric Disease Designation for NEO100 in Treatment of Pediatric-Type Diffuse High-Grade Gliomas
-
Atsign Advances Private Website Security with the Power of Invisibility
-
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
-
Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib
-
TOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1
-
Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update
-
CG Oncology to Participate in the 120th American Urological Association Annual Meeting with a Series of Key Presentations and Updates
